
Panel Discussion – The Value and Challenges
of Evidence from Observational Data: A
Multi-Stakeholder Perspective
• Moderator: David Madigan, PhD, Executive Vice
President and Dean of the Faculty of Arts and
Sciences at Columbia University
• Robert Ball, MD, MPH, ScM, Deputy Director – Office
of Surveillance and Epidemiology, CDER, US Food
and Drug Administration
• Invited: Robert Califf, MD, Deputy Commissioner of
Medical Products and Tobacco, US Food and Drug
Administration
• Nareesa Mohammed-Rajput, MD, Medical Director
of Clinical Informatics, Suburban Hospital part of
Johns Hopkins Medicine
• Maryan Zirkle MD, MS, MA, Program Officer – CER
Methods and Infrastructure Program, PCORI
• Lesley Wise, Vice President of PV Risk Management
and Pharmacoepidemiology, Takeda Pharmaceuticals